REP. TOWNS ASKS FDA FOR TMJ-RELATED DOCUMENTATION
This article was originally published in The Gray Sheet
Executive Summary
REP. TOWNS ASKS FDA FOR TMJ-RELATED DOCUMENTATION in a letter sent to FDA Commissioner David Kessler Sept. 14. Rep. Edolphus Towns (D-N.Y.), chairman of the House Government Operations/Human Resources and Intergovernmental Relations Subcommittee, asked for information on adverse incident reports and FDA inspections related to temporomandibular joint implants, as well as data regarding the regulation of Silastic TMJ implants and TMJ materials manufactured by Dow Coming.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.